Articles Posted in Pharmaceutical Errors

by

Second chances are rare in medicine. Oftentimes doctors and nurses have one chance to get something right, which means that medical providers need to monitor patients’ reactions to different treatment modalities. When they see something that is not right, medical providers need to pick up on the warning signs and correct the problem because chances are they will only get one chance to do so.

However, in the case of Kerry Rupright, doctors missed their chance to prevent Kerry’s permanent brain injury from happening. They missed the signs that should have alerted them that she was not reacting well to her various medications, instead opting to continue her treatment plan. The medical malpractice lawsuit of Estate of Kerry Rupright v. Rehabilitation Institute of Chicago, et al., 05 L 9451, was filed in an effort to hold these doctors accountable for their lack of vigilance in monitoring Kerry’s condition.

Kerry presented to Rehabilitation Institute of Chicago for treatment of her transverse myelitis, which is inflammation across one section of the spinal cord. Transverse myelitis is extremely painful, so Kerry was prescribed pain medications as part of her treatment plan. Specifically, Kerry was given a pain relief patch that contained Duragesic and Fentanyl, which can cause respiratory distress when taken with other medications.

Continue reading

by

Topamax is an anticonvulsant medication that is prescribed to treat epilepsy and the associated seizures, or can also be prescribed to prevent migraine headaches. Recently, the Food and Drug Administration (FDA) released a new warning about some birth defects associated with Topamax. Specifically, the drug warning states that mothers taking Topamax showed higher incidences of cleft lips and cleft palates than mothers not taking Topamax.

This discovery was made by the North American Antiepileptic Drug (NAAED) Pregnancy Registry, whose data showed that 1.4% of infants exposed to Topamax during the first trimester were likely to develop a cleft lip or cleft palate. The prevalence of cleft lips or palate in infants with no exposure to anticonvulsant medications was 0.07%.

In light of this new information, the FDA elevated the Topamax’s pregnancy category from C to D. Under Category D, “There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in
pregnant women despite potential risks.” Physicians are advised not to prescribe Topamax to pregnant women unless the potential benefits of the drug outweigh the potential risks to the fetus.

Continue reading

by

A $14.9 million settlement was reached in an Illinois medical malpractice case that left the plaintiff with permanent brain damage. The lawsuit of Jennifer Lee v. Palos Community Hospital, et al., 09 L 7824, was brought against the hospital where the plaintiff was treated, as well as the individual doctors who treated the plaintiff.

In 2009, plaintiff, Jennifer Lee, presented to Palos Community Hospital with severe dehydration from vomiting and diarrhea. The typical treatment for dehydration is to pump the patient with IV fluids and monitor their electrolyte levels. When Ms. Lee presented to the hospital, her initial blood work showed an extremely high level of sodium. While normal sodium levels range from 135 mmol/L to 145 mmol/L, Ms. Lee’s sodium level was at 165 mmol/L.

Typically, dehydration results in low sodium levels, not high sodium levels. Blood sodium levels can indicate whether there is an imbalance between the levels of sodium and water in your body. While Ms. Lee’s initial sodium levels were critically high, it fluctuated between critically high and critically low during the course of her admission. In fact, it was this change from critically high, to critically low, then back to critically high that caused the plaintiff’s brain damage and was the subject of her medical malpractice lawsuit.

Continue reading